MX2020011631A - Ensayo de acetaminofeno. - Google Patents

Ensayo de acetaminofeno.

Info

Publication number
MX2020011631A
MX2020011631A MX2020011631A MX2020011631A MX2020011631A MX 2020011631 A MX2020011631 A MX 2020011631A MX 2020011631 A MX2020011631 A MX 2020011631A MX 2020011631 A MX2020011631 A MX 2020011631A MX 2020011631 A MX2020011631 A MX 2020011631A
Authority
MX
Mexico
Prior art keywords
assay
present
acetaminophen
acetaminophen assay
sample
Prior art date
Application number
MX2020011631A
Other languages
English (en)
Inventor
Robert Acorn
Helen Coady
Graham Coll
Original Assignee
Sekisui Diagnostics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Diagnostics Llc filed Critical Sekisui Diagnostics Llc
Publication of MX2020011631A publication Critical patent/MX2020011631A/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/583—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with non-fluorescent dye label
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
    • C12Y305/01—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in linear amides (3.5.1)
    • C12Y305/01013—Aryl-acylamidase (3.5.1.13)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/978—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
    • G01N2333/98—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

La presente invención se refiere a un ensayo para determinar la concentración de p-aminofenol presente en una muestra. Más particularmente, la presente invención se refiere a un mejoramiento de un ensayo a base de enzima para determinar la concentración de acetaminofeno presente en una muestra.
MX2020011631A 2018-05-03 2019-05-03 Ensayo de acetaminofeno. MX2020011631A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201862666282P 2018-05-03 2018-05-03
PCT/US2019/030558 WO2019213489A1 (en) 2018-05-03 2019-05-03 Acetaminophen assay

Publications (1)

Publication Number Publication Date
MX2020011631A true MX2020011631A (es) 2021-04-12

Family

ID=68383705

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020011631A MX2020011631A (es) 2018-05-03 2019-05-03 Ensayo de acetaminofeno.

Country Status (8)

Country Link
US (1) US20190338337A1 (es)
EP (1) EP3813812A4 (es)
JP (1) JP7465257B2 (es)
CN (1) CN112702996A (es)
BR (1) BR112020022414A2 (es)
CA (1) CA3099277C (es)
MX (1) MX2020011631A (es)
WO (1) WO2019213489A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102018100426A1 (de) * 2018-01-10 2019-07-11 Diasys Diagnostic Systems Gmbh Quantitative Acetaminophen-Analytik
CN112255395B (zh) * 2020-12-23 2021-06-18 中生北控生物科技股份有限公司 一种消除脂血样本中乳糜干扰的方法和免疫浊度法试剂盒及应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US415929A (en) * 1889-11-26 Richard walsh
US4154929A (en) * 1976-08-16 1979-05-15 American Monitor Corporation 9-(2-Pyridyl)-acenaphtho[1,2-e]-as-triazines
US4224034A (en) * 1978-09-07 1980-09-23 American Monitor Corporation Assay of iron and iron binding protein reagents and methods
US5151370A (en) * 1990-10-11 1992-09-29 Synermed, Inc. Reagent and method for serum iron assay
CA2178048C (en) * 1995-06-22 2009-08-11 Thomas C. Arter Dry analytical element for acetaminophen assay
JP4345956B2 (ja) * 2003-01-15 2009-10-14 国立大学法人 宮崎大学 農園芸用抗菌溶液およびその製造方法
BRPI0911578B8 (pt) * 2008-04-28 2021-07-27 Genzyme Corp método e conjunto para determinação da concentração de acetaminofeno em uma amostra

Also Published As

Publication number Publication date
BR112020022414A2 (pt) 2021-02-02
JP7465257B2 (ja) 2024-04-10
US20190338337A1 (en) 2019-11-07
WO2019213489A1 (en) 2019-11-07
EP3813812A1 (en) 2021-05-05
JP2021523383A (ja) 2021-09-02
CA3099277C (en) 2024-01-23
CN112702996A (zh) 2021-04-23
CA3099277A1 (en) 2019-11-07
EP3813812A4 (en) 2022-01-12

Similar Documents

Publication Publication Date Title
WO2020123316A3 (en) Methods for determining a location of a biological analyte in a biological sample
MA49034B1 (fr) Anticorps anti-lag3
MX2017003478A (es) Anticuerpos anti-fgfr2/3 y metodos para su uso.
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
MX2017016647A (es) Anticuerpos y fragmentos anti-vista.
ATE485359T1 (de) Verwendung von grenzflächenaktiven, nicht- enzymatischen proteinen für die textilwäsche
MX2020010951A (es) Anticuerpos anti-hla-g y utilizacion de los mismos.
EA201692157A1 (ru) Синтез двухцепочечных нуклеиновых кислот
EP4273092A3 (en) Method and apparatus for determining the presence, absence or characteristics of an analyte
MX2016016742A (es) Ceramidas y su uso en el diagnostico de enfermedad cardiovascular (ecv).
TR201909037T4 (tr) Yeni protein deamidaz.
BR112017016897A2 (pt) cepas fúngicas e métodos de uso
EA201892325A1 (ru) Композиции и способы детектирования белков клетки-хозяина
CR20220156A (es) Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecíficos anti-klk5/klk7 y métodos de uso
MX2022005091A (es) Metodos de preparacion de una muestra enriquecida para la secuenciacion de polipeptidos.
PH12016501579B1 (en) Novel anti-presepsin antibody
MX2020011631A (es) Ensayo de acetaminofeno.
EA201892005A1 (ru) Композиции и способы для лечения ревматоидного артрита
GB2542576A (en) Method and kit of detecting the absence of micro-oranisms
SG11201907866SA (en) Horseshoe crab factor b variant
MY179359A (en) Methods for purification of a virus produced in vitro and clearance assay for the virus
EA201992168A1 (ru) Аналоги деутетрабеназина, их получение и применение
MX2019011702A (es) Ensayos de inmunogenicidad mejorados.
MA46988A1 (fr) Formulation liquide d'anticorps anti-tnf alpha
MA45831B1 (fr) Anticorps monoclonaux anti-punaises de lit et leurs procédés de production et d'utilisation